Janus Henderson Group’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.1M | Sell |
509,321
-1,284,512
| -72% | -$55.8M | 0.01% | 546 |
|
|
2025
Q1 | $71.3M | Buy |
1,793,833
+658,733
| +58% | +$26.2M | 0.04% | 311 |
|
|
2024
Q4 | $51.5M | Buy |
1,135,100
+665,543
| +142% | +$30.2M | 0.03% | 384 |
|
|
2024
Q3 | $27.6M | Buy |
469,557
+458,157
| +4,019% | +$26.9M | 0.01% | 508 |
|
|
2024
Q2 | $449K | Buy |
11,400
+5,290
| +87% | +$208K | ﹤0.01% | 2044 |
|
|
2024
Q1 | $406K | Sell |
6,110
-473,576
| -99% | -$31.4M | ﹤0.01% | 2105 |
|
|
2023
Q4 | $13.4M | Sell |
479,686
-118,809
| -20% | -$3.32M | 0.01% | 621 |
|
|
2023
Q3 | $12.7M | Buy |
+598,495
| New | +$12.7M | 0.01% | 618 |
|